FDA Clears New 128-Slice CT System from Fujifilm
Proprietary technologies with the FCT iStream computed tomography system reportedly facilitate enhanced workflow efficiency and significantly reduced radiation dosing.
Offering the capability to capture 60 images per second and technology that may reduce radiation dosing by up to 83 percent, the FCT iStream computed tomography (CT) system has garnered 510(k) clearance from the Food and Drug Administration (FDA).
Core proprietary technologies with the FCT iStream system significantly rein in radiation dosing, according to Fujifilm, the manufacturer of the device.
Based on patient attenuation, the IntelliODM feature adjusts dosage as per angular and/or CT slice directions. Through a combination of iterative progressive reconstruction and visual modeling (IPV), Fujifilm emphasized that Intelli IPV may provide up to an 83 percent reduction in radiation dosing and up to a 90 percent noise reduction.
Through a combination of iterative progressive reconstruction and visual modeling (IPV), Fujifilm emphasized that the Intelli IPV feature in the newly FDA-cleared FCT iStream system (shown above) may provide up to an 83 percent reduction in radiation dosing and up to a 90 percent noise reduction. (Image courtesy of Fujifilm.)
In addition to obtaining 60 images per second, the FCT iStream’s SynergyDrive technology promotes increased workflow efficiency through automated patient positioning with optimal imaging parameters as well as image archiving.
“Staff shortages, increased financial pressure and escalating patient demand are driving radiology departments to look for ways to streamline workflow, avoid repeat scans and ensure they are maximizing throughput,” said Shawn Etheridge, executive director, of modality solutions for FUJIFILM Healthcare Americas Corporation. “We’ve designed FCT iStream to reduce the pain points these high-volume departments face by engineering an intelligent, reliable, imaging solution that will help automate clinician’s most time-consuming steps.”
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
